Clinical Trials Browser

Withdrawn × OTHER × Transplantation Conditioning × Clear all

NCT02053545 2019-08-30

Haplo-identical SCT for High Risk (HR) Hematologic Malignancies w/Post-Transplant In-Vivo T-cell Depletion

Phase 1/2 Withdrawn

LymphoidOther hematologic neoplasm

Leukemia, Lymphoma

NCT02378922 2018-12-27

Gene-Modified HIV-Protected Stem Cell Transplant in Treating Patients With HIV-Associated Lymphoma

Phase 1 Withdrawn

Hodgkin Disease, Lymphoma, Non-Hodgkin, HIV Infections